Medtronic gains FDA approval for longer DCB to treat patients with SFA disease

Medtronic announced that the FDA has approved a longer length of its drug-coated balloon for treatment of superficial femoral artery disease. http://www.healio.com/cardiac-vascular-intervention/peripheral/news/online/%7Bc4d7b439-44fc-4dd4-a5dc-267c2eef0582%7D/medtronic-gains-fda-approval-for-longer-dcb-to-treat-patients-with-sfa-disease

Healio